PubRank

Rie Igarashi

Author PubWeight™ 22.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome sequencing and analysis of Aspergillus oryzae. Nature 2005 5.47
2 Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles. Pharm Res 2009 1.23
3 Therapeutic effect of lecithinized superoxide dismutase against colitis. J Pharmacol Exp Ther 2008 1.01
4 Mature adipocyte-derived cells, dedifferentiated fat cells (DFAT), promoted functional recovery from spinal cord injury-induced motor dysfunction in rats. Cell Transplant 2008 0.99
5 Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats. J Control Release 2007 0.95
6 Prostaglandin E2 production in ovarian cancer cell lines is regulated by cyclooxygenase-1, not cyclooxygenase-2. Prostaglandins Leukot Essent Fatty Acids 2005 0.89
7 A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release. J Control Release 2002 0.84
8 Optimum formulation for sustained-release insulin. Int J Pharm 2004 0.84
9 Octaarginine-modified liposomes enhance the anti-oxidant effect of Lecithinized superoxide dismutase by increasing its cellular uptake. Biochem Biophys Res Commun 2010 0.83
10 Effects of prolonged delivery of brain-derived neurotrophic factor on the fate of neural stem cells transplanted into the developing rat retina. Biochem Biophys Res Commun 2003 0.83
11 Successful treatment of photo-damaged skin of nano-scale atRA particles using a novel transdermal delivery. J Control Release 2005 0.83
12 Lecithinized superoxide dismutase (PC-SOD) improved spinal cord injury-induced motor dysfunction through suppression of oxidative stress and enhancement of neurotrophic factor production. J Control Release 2005 0.83
13 A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo. J Pharm Pharmacol 2002 0.81
14 Lecithin-bound superoxide dismutase in the treatment of noninfectious corneal ulcers. Am J Ophthalmol 2003 0.80
15 Effects of inducible nitric oxide synthase inhibitors on asthma depending on administration schedule. Free Radic Biol Med 2005 0.80
16 [Remarkable effect of gemcitabine-oxaliplatin (GEMOX) therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas]. Gan To Kagaku Ryoho 2008 0.79
17 Transdermal delivery of CaCO3-nanoparticles containing insulin. Diabetes Technol Ther 2006 0.79
18 Synthesis of prostaglandin E(1) phosphate derivatives and their encapsulation in biodegradable nanoparticles. Pharm Res 2009 0.78
19 Lecithinized brain-derived neurotrophic factor promotes the differentiation of embryonic stem cells in vitro and in vivo. Biochem Biophys Res Commun 2005 0.77
20 The effect of Am-80, a synthetic retinoid, on spinal cord injury-induced motor dysfunction in rats. Biol Pharm Bull 2009 0.77
21 Nano PGE1 promoted the recovery from spinal cord injury-induced motor dysfunction through its accumulation and sustained release. J Control Release 2010 0.76
22 Plasma as a scaffold for regeneration of neural precursor cells after transplantation into rats with spinal cord injury. Cell Transplant 2007 0.75
23 [Prolonged release microcapsules of insulin for complement of the basal secretion]. Nihon Rinsho 2002 0.75
24 [Nanotechnology for therapy of type 2 diabetes]. Nihon Rinsho 2006 0.75
25 [Comparison study of lipo PGE1 preparations]. Yakugaku Zasshi 2007 0.75